C9orf72 and amyotrophic lateral sclerosis: Moreover, Tran and collaborators [274] have demonstrated that the expression of 160 G4C2 repeats did not induce toxicity through nuclear RNA foci but rather through cytoplasmic DPR proteins, suggesting that reducing repeat protein presence could be beneficial to ALS patients with C9orf72 mutations.